“SAFETY, EFFICACY, AND EFFECTIVENESS OF BRENTUXIMAB VEDOTIN IN THE TREATMENT OF RELAPSED OR REFRACTORY CD30+ HODGKIN LYMPHOMA AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION: A SYSTEMATIC REVIEW”, REMUNOM, vol. 2, no. 02, pp. 1–23, Feb. 2026, doi: 10.66104/hkgjcw62.